TNF and inflammatory bowel disease: The monoclonal antibodies against tumor necrosis factor (TNF) – infliximab (IFX) and adalimumab (ADA) – are increasingly used to treat inflammatory bowel disease (IBD) that is refractory to standard medication (1).